NEW YORK, Feb. 13, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Nanotechnology for Drug Delivery : Global Market for Nanocarriers
Nanocarriers will account for 40% of a $136 billion nanotechnology-enabled drug delivery market by 2021. We forecast the total market size in 2021 to be US$136 billion, with a 60/40 split between nanocrystals and nanocarriers respectively, although developing new targeted delivery mechanisms may allow more value to be created for companies and entrepreneurs.
Of the 10 nanocarrier technologies studied, liposomes and gold nanocarriers account for 45% of the total addressable market. Liposomes will offer the largest addressable market ($15 billion) in 2021 while gold nanocarriers will see the highest compound annual growth rate (CAGR)—53.8%—in the next decade.
Drugs are loaded into nanocarriers (also called nanoshells or nanoparticles, between 1 and 100 nm), then transported through the body to the target site. This kind of targeted drug delivery for the treatment of cancers is one of the most anticipated and discussed benefits of nanotechnology-enabled medicine as it offers a level of accuracy in delivering drugs that far surpasses present methods. Typically over 90% of a drug is wasted in the body, which leads to unwanted side effects. Modern chemotherapy bombards patients with drugs in the hope that tumorous cells will be destroyed. The lack of specificity of current drug delivery techniques mean patients' healthy cells are destroyed indiscriminately along with cancer cells.
Using nanotechnology to combat cancer is not new. Abraxane, the first nanoparticulate drug delivery product for the treatment of breast cancer, launched six years ago. There are now hundreds of new nanotech-based treatments under development, ranging from reformulation of existing drugs to enhance their efficacy to radical new "magic bullet" therapies.
The healthcare market is changing. We are seeing a paradigm shift away from blockbusters and a 'one-size fits all' approach to a more personalised medicine based on an individual's unique genome and immune response. The more scientists learn about the molecular causes for disease the more targeted and effective nanotechnology-enabled drug delivery therapies will become.
Table of ContentsTABLE OF EXHIBITS 7
EXECUTIVE SUMMARY 12
CHAPTER 1 - INTRODUCTION 17REPORT SCOPE 17
METHODOLOGY 18
Procurement 18
Calculation of CAGR 19
THE NANOSCALE 20
Two biological examples that illustrate nanoscale: 20
CHAPTER 2 – NANOTECHNOLOGY IN MEDICINE AND BIOMEDICINE 22OVERVIEW OF NANOTECHNOLOGY IN MEDICINE AND BIOMEDICINE 22
Why is Nanotechnology A Critical Application for Medicine and Biomedicine? 22
Why Nanotechnology Is Needed for Medicine and Biomedicine 24
WHAT ARE THE KEY DRIVERS FOR ADOPTION OF NANOTECHNOLOGY IN MEDICINE AND
BIOMEDICINE? 27
The Aim Of Drug Targeting 27
Rapid Market Growth 28
Market Drivers For Enhanced Drug Delivery 28
Increasing Proportion of The Ageing Population 29
Demand For More Affordable Health Care 31
Public Health – Ending disease 31
Demand for More Innovation 31
Social responsibility 31
THE KEY APPLICATIONS OF NANOTECHNOLOGY IN MEDICINE AND BIOMEDICINE 32
How Nanotechnology Can Benefit Drug Delivery 33
Nanotechnology in Medical and Biomedical Diagnostics 34
Nanotechnology in Regenerative Medicine and Tissue Engineering 34
Other Applications For Nanomaterials In The Medical And Pharmaceutical Sector 34
PROMISING EXAMPLES OF NANOTECHNOLOGY ENABLED DRUG DELIVERY 35
Case Study 1 – Magnetic Field Acts as "Remote Control" to Deliver Nanomedicine 35
Case Study 2 - Adaptive Micro and Nanoparticles: Temporal Control Over Carrier
Properties to Facilitate Drug Delivery 36
Case Study 3 – Fabrication of a Nanocarrier System Through Self-Assembly of Plasma
Protein And Its Tumour Targeting 39
Case Study 4 – IBM And The Institute of Bioengineering And Nanotechnology Find
Breakthrough For MRSA 39
CHAPTER 3 – RISK & REGULATION 43THREE KEY BARRIERS TO THE ADOPTION OF NANOTECHNOLOGY IN MEDICINE AND
BIOMEDICINE 43
Nanotoxicity Nanopollution and Nanosafety 43
Ethical Considerations Of Nanotherapies 45
Delayed Nanoregulation 46
FIVE CURRENT & FUTURE CHALLENGES IN THE ADOPTION OF NANOTECHNOLOGY IN
MEDICINE AND BIOMEDICINE 48
Current & Future Challenges of Nanosafety And Risk Management 48
Current & Future Challenges of Nanoregulation 51
Current & Future Challenges for the Nanomedicine Industry 53
Current & Future Challenges of Sustained Innovation 54
Current & Future Challenges of Cooperation 54
CHAPTER 4 – MARKET FOR NANOCARRIERS 57GLOBAL MARKET ANALYSIS: 2000-2010 (WITHOUT SEGMENTATION) 57
GLOBAL MARKET FORECAST: 2011-2021 (WITHOUT SEGMENTATION) 60
DISCUSSION OF NANOPARTICLES & NANOCARRIERS 63
Overview of The Key Nanotechnologies Used in Drug Delivery Sorted by Applications 63
Nanopharmaceuticals 63
Nanotechnology In Drug Delivery 63
Nanobiotechnology In Drug Delivery 64
Analytical Techniques For Nanoparticle Drug Delivery 65
Properties 65
Production of Nanoparticles 65
Measuring Dispersion of Nanoparticles 66
Characterisation of Carrier Systems 67
Nanocarriers 68
Classification of Nanocarriers 68
Multifunctional Nanocarriers - Drug Delivery And Medical / Biomedical Diagnostics 69
Nanocarriers as Drug Carriers 69
What Can Nanoparticles do in Drug Delivery? 69
Polymer-Based Nanocarriers (Polymeric Nanoparticles) 73
Lipid-Based Nanocarriers 75
Organic Nanocarriers 78
Inorganic Nanocarriers 78
Disadvantages Associated With Nanocarriers 79
The Most Relevant Technologies in The Key Area of Nanotechnology in Drug Delivery 80
Stage of Development of Key Nanotechnologies Used in Drug Delivery 80
Clinically Approved Nanocarrier-Based Drug Formulations With Presence on The Market
The First Nanoparticle Drug Delivery System Reaches The Market 81
Present And Future Applications 84
TECHNOLOGY ADOPTION ROADMAP 86
Projected Product Pipeline For Nanocarrier-Based Drug Formulations In Drug Delivery
Market 86
Available Applications Of Nanoparticles In Drug Delivery 87
Semapimod® (cytokine, pharmasciences) 89
Paxceed™ 89
Theralux™ 90
Nucryst® 90
iSPERSE™ 91
ANALYSIS OF TAM FOR NANOCARRIERS: 2000-2010 93
TAM FORECAST FOR NANOCARRIERS: 2011-2021 99
APPENDIX 108
PUBLISHING ACTIVITY BY ORGANIZATION (2000-2010) 108
To order this report:Drug Delivery Technology Industry: Nanotechnology for Drug Delivery : Global Market for Nanocarriers
More Market Research Report
Check our Industry Analysis and Insights
Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626
More:
Nanotechnology for Drug Delivery : Global Market for Nanocarriers
Recommendation and review posted by G. Smith
